It is just the study that has been done in the last month,
it involved 22 patients including a healthy heart, 2 x SAVR, Evolut, Sapien and DurAVR.
Patients probably isn’t the correct term considering there was a healthy heart included in the study.
- Forums
- ASX - By Stock
- AVR
- New CEO Proactive video interview
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$5.91

New CEO Proactive video interview, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.000(0.00%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$5.93 | $5.95 | $5.91 | $3.261K | 551 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.00 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 5.900 |
2 | 1943 | 5.870 |
1 | 319 | 5.840 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.000 | 1000 | 1 |
6.070 | 43 | 1 |
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.400 | 130 | 1 |
Last trade - 10.35am 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online